UCB reports positive phase 3 results for fenfluramine in CDKL5 disorder - wealthalpha

Factbox-Corporate America continues job cuts in 2026 in efficiency push

24 March, 2026

UCB reports positive phase 3 results for fenfluramine in CDKL5 disorder

December 8, 2025

by wealthalpha

Other news

UCB reports positive phase 3 results for fenfluramine in CDKL5 disorder

Source link

wealthalpha

Leave A Comment Cancel reply